Stock Events

Stock Events

Boule Diagnostics AB 

$7.84
0
+$0+0% Monday 20:00

Statistics

Day High
3.51
Day Low
3.51
52W High
7.84
52W Low
3.51
Volume
2,000
Avg. Volume
0
Mkt Cap
304.45M
P/E Ratio
41.26
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
May 22
$0.06
May 21
$0.07
May 19
$0.06
May 17
$0.04
May 16
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

28AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.03
0.53
1.1
1.67
Expected EPS
0.1484088486
Actual EPS
N/A

Financials

-52.82%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
101.4MRevenue
-53.56MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BDABF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Danaher
DHR
Mkt Cap152.13B
Danaher Corporation owns Beckman Coulter, which produces hematology analyzers competing directly with Boule Diagnostics' products.
Resmed
RMD
Mkt Cap36.04B
ResMed Inc. operates in the medical equipment sector, providing products that overlap with the diagnostic and health monitoring solutions offered by Boule Diagnostics.
Bio-Rad Laboratories
BIO
Mkt Cap8.54B
Bio-Rad Laboratories, Inc. offers a range of clinical diagnostic products that compete in the same space as Boule Diagnostics.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific Inc. provides analytical instruments and diagnostic equipment, competing in the laboratory equipment sector alongside Boule Diagnostics.
Becton Dickinson
BDX
Mkt Cap51.22B
Becton, Dickinson and Company manufactures and sells medical devices and instrument systems, including those for diagnostics, competing with Boule Diagnostics.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers diagnostic systems and tests, including hematology, which competes with Boule Diagnostics' hematology analyzers.
Agilent Technologies
A
Mkt Cap41.49B
Agilent Technologies, Inc. provides instruments, services, and consumables for labs, including those in diagnostics, competing with Boule Diagnostics.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. specializes in diagnostics and medical imaging systems, which places them in competition with Boule Diagnostics in the diagnostics market.
Guardant Health
GH
Mkt Cap11.72B
Guardant Health, Inc. focuses on oncology diagnostics, competing indirectly by offering alternative diagnostic solutions in the healthcare market.

About

Medical Specialties
Health Technology
Boule Diagnostics AB (publ) develops, manufactures, and markets instruments and consumable products for blood diagnostics in the United States of America, Asia, Eastern Europe, Latin America, Western Europe, Africa, and the Middle East. The company provides hematology analyzers, reagents, controls, and calibrators, under the Swelab, Medonic, and Quintus brands; and veterinary hematology and clinical chemistry analyzer systems, as well as reagents and panels under the Exigo brand. It serves small and medium-sized hospitals, clinics, laboratories, and veterinary clinics, and other diagnostics companies. Boule Diagnostics AB (publ) was founded in 1956 and is headquartered in Spånga, Sweden.
Show more...
CEO
Jesper Soderqvist
Country
SE
ISIN
SE0011231158

Listings

Grey Market
US
BDABF
ST
SE
BOUL.ST

0 Comments

Share your thoughts

FAQ

What is Boule Diagnostics AB stock price today?▼
The current price of BDABF is $7.84 USD — it has increased by +0% in the past 24 hours. Watch Boule Diagnostics AB stock price performance more closely on the chart.
What is Boule Diagnostics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Boule Diagnostics AB stocks are traded under the ticker BDABF.
What is Boule Diagnostics AB market cap?▼
Today Boule Diagnostics AB has the market capitalization of 304.45M
When is the next Boule Diagnostics AB earnings date?▼
Boule Diagnostics AB is going to release the next earnings report on April 28, 2026.
What were Boule Diagnostics AB earnings last quarter?▼
BDABF earnings for the last quarter are 0.01 USD per share, whereas the estimation was 0.01 USD resulting in a -26.34% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Boule Diagnostics AB revenue for the last year?▼
Boule Diagnostics AB revenue for the last year amounts to 101.4M USD.
What is Boule Diagnostics AB net income for the last year?▼
BDABF net income for the last year is -53.56M USD.
Does Boule Diagnostics AB pay dividends?▼
Yes, BDABF dividends are paid annual. The last dividend per share was 0.06 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Boule Diagnostics AB located?▼
Boule Diagnostics AB operates in the Manufacturing sector.
When did Boule Diagnostics AB complete a stock split?▼
The last stock split for Boule Diagnostics AB was on June 07, 2018 with a ratio of 4:1.
Where is Boule Diagnostics AB headquartered?▼
Boule Diagnostics AB is headquartered in Spanga, SE.